Author

Dimitrios K. Christodoulou

TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE
TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE

Dimitrios K. Christodoulou  et al.

PERCEPTIONS AND PRACTICES ON CLINICAL USE OF PROBIOTICS: A NATIONAL SURVEY OF HEALTHCARE PRACTITIONERS
PERCEPTIONS AND PRACTICES ON CLINICAL USE OF PROBIOTICS: A NATIONAL SURVEY OF HEALTHCARE PRACTITIONERS

Dimitrios K. Christodoulou  et al.

THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD
THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD

Dimitrios K. Christodoulou  et al.

TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY
TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY

Dimitrios K. Christodoulou  et al.

“REAL WORLD” PRELIMINARY DATA ON THE EFFICACY AND SAFETY OF 16-WEEK INDUCTION THERAPY WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS
“REAL WORLD” PRELIMINARY DATA ON THE EFFICACY AND SAFETY OF 16-WEEK INDUCTION THERAPY WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS

Dimitrios K. Christodoulou  et al.

THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB
THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB

Dimitrios K. Christodoulou  et al.

PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY
PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY

Dimitrios K. Christodoulou  et al.

HEAVY PSEUDOPOLYP BURDEN IN INFLAMMATORY BOWEL DISEASE PREDICTS MORE SEVERE DISEASE: A MULTICENTRE COHORT STUDY
HEAVY PSEUDOPOLYP BURDEN IN INFLAMMATORY BOWEL DISEASE PREDICTS MORE SEVERE DISEASE: A MULTICENTRE COHORT STUDY

Dimitrios K. Christodoulou  et al.

Item 1 - 8 / 8
1